DiscoverThe Lancet Psychiatry in conversation withMikkel Højlund on antipsychotics polypharmacy
Mikkel Højlund on antipsychotics polypharmacy

Mikkel Højlund on antipsychotics polypharmacy

Update: 2024-11-12
Share

Description

Sophia Davis talks to Mikkel Højlund about research into the prevalence and outcomes of antipsychotics polypharmacy.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Mikkel Højlund on antipsychotics polypharmacy

Mikkel Højlund on antipsychotics polypharmacy

The Lancet Group